• Publications
  • Influence
Phase II Safety and Efficacy Study of CT-011, a Humanized Anti-PD-1 Monoclonal Antibody, in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma
Abstract 793 Background: Follicular lymphoma (FL) is one of the most immune-responsive of all cancers. However, immunosuppressive mechanisms in the tumor microenvironment may impair optimal antitumorExpand
  • 3
Improving the peri‐operative pathway of people with diabetes undergoing elective surgery: the IP3D project
To determine whether outcomes for people with diabetes undergoing elective surgery improve following the introduction of innovations in the peri‐operative care pathway.
Immunological Effects and Predictive Gene Signatures in Patients with Relapsed Follicular Lymphoma Treated with CT-011, a Humanized Anti-PD-1 Monoclonal Antibody
Abstract 162 Background: The coinhibitory receptor programmed death (PD)-1 is markedly increased on peripheral blood (PB) and intratumoral T cells in follicular lymphoma (FL) and is associated withExpand
  • 1
Response rates and lesion-level progression patterns of solid tumor patients in an academic phase I program: implications for tumour heterogeneity
Abstract Background Sequencing studies have demonstrated extensive genetic heterogeneity between and within tumor lesions in treated metastatic solid tumor patients. The response of individual tumorExpand
Developing culturally sensitive parent education programs for immigrant families: The helping youth succeed curriculum
This paper describes the process by which the Helping Youth Succeed (HYS) curriculum was developed for Cambodian, Hmong, Lao, and Vietnamese immigrants in the United States to help address andExpand
  • 12
  • PDF